FDA Urged to Ban Ortho Evra Birth Control Patch
Public Citizen, a nonprofit consumer advocacy program, petitioned the FDA asking that it pull Ortho Evra from the market.
Otho Evra, more commonly known as the “birth control patch” or simply “the patch” is about twice as likely to cause blood clots as the birth control pill. That’s because women who use the patch are exposed to a dose of estrogen that is 60% higher than the dose in the pill.
Public Citizen has a long history of success in helping keep dangerous drugs off the market. To name a few victories:
- 1976: a Public Citizen petition lead an FDA ban of chloroform, a cancer-causing chemical, in cough medicine and toothpaste.
- 1982: Oraflex, an arthritis drug, was taken off the market after Public Citizen exposed that it was causing injuries, including death.
- 1985: Upon urging from Public Citizen, the FDA required a label change for aspirin warning of the link between Reye’s Syndrome and the use of aspirin in children.
- 1986: Public Citizen obtained a court order requiring the FDA to add a warning regarding Toxic Shock Syndrome to tampon labels.
- 1996: Public Citizen won a Supreme Court case, confirming the right of injured people to sue medical device manufacturers.
- 2000: Public Citizen lead efforts to ban Rezulin, a deadly diabetes drug.
To read the petition, click here: http://www.citizen.org/pressroom/release.cfm?ID=2654
If you or someone you love has been hurt by Ortho Evra, you may be entitled to compensation. Contact the expert Ortho Evra attorneys at Schlichter Bogard and Denton for a free consultation.